AstraZeneca Inks $51.4M Settlement In Pay-For-Delay Case

AstraZeneca Pharmaceuticals LP and Handa Pharmaceuticals LLC have agreed to shell out a combined $51.4 million to put to rest allegations AstraZeneca paid off generic-drug makers, including Handa, to protect its brand...

Already a subscriber? Click here to view full article